Ratain MJ - Search Results

1

Genetic variation determines VEGF-A plasma levels in cancer patients.

Innocenti F, Jiang C, Sibley AB, Etheridge AS, Hatch AJ, Denning S, Niedzwiecki D, Shterev ID, Lin J, Furukawa Y, Kubo M, Kindler HL, Auman JT, Venook AP, Hurwitz HI, McLeod HL, Ratain MJ, Gordan R, Nixon AB, Owzar K. Innocenti F, et al. Among authors: ratain mj. Sci Rep. 2018 Nov 5;8(1):16332. doi: 10.1038/s41598-018-34506-4. Sci Rep. 2018. PMID: 30397360 Free PMC article.

2

Dose-escalating study of capecitabine plus gemcitabine combination therapy in patients with advanced cancer.

Schilsky RL, Bertucci D, Vogelzang NJ, Kindler HL, Ratain MJ. Schilsky RL, et al. Among authors: ratain mj. J Clin Oncol. 2002 Jan 15;20(2):582-7. doi: 10.1200/JCO.2002.20.2.582. J Clin Oncol. 2002. PMID: 11786589 Clinical Trial.

3

Phase I clinical and pharmacokinetic study of protein kinase C-alpha antisense oligonucleotide ISIS 3521 administered in combination with 5-fluorouracil and leucovorin in patients with advanced cancer.

Mani S, Rudin CM, Kunkel K, Holmlund JT, Geary RS, Kindler HL, Dorr FA, Ratain MJ. Mani S, et al. Among authors: ratain mj. Clin Cancer Res. 2002 Apr;8(4):1042-8. Clin Cancer Res. 2002. PMID: 11948111 Clinical Trial.

4

Correspondence re: Raida, M. et al., prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5'-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)-related toxicity compared with controls.

Innocenti F, Ratain MJ. Innocenti F, et al. Among authors: ratain mj. Clin Cancer Res. 2002 May;8(5):1314; author reply 1315-6. Clin Cancer Res. 2002. PMID: 12006555 No abstract available.

5

In vitro characterization of hepatic flavopiridol metabolism using human liver microsomes and recombinant UGT enzymes.

Ramírez J, Iyer L, Journault K, Bélanger P, Innocenti F, Ratain MJ, Guillemette C. Ramírez J, et al. Among authors: ratain mj. Pharm Res. 2002 May;19(5):588-94. doi: 10.1023/a:1015341726183. Pharm Res. 2002. PMID: 12069159

6

Interethnic difference in the allelic distribution of human epidermal growth factor receptor intron 1 polymorphism.

Liu W, Innocenti F, Chen P, Das S, Cook EH Jr, Ratain MJ. Liu W, et al. Among authors: ratain mj. Clin Cancer Res. 2003 Mar;9(3):1009-12. Clin Cancer Res. 2003. PMID: 12631599

7

Irinotecan treatment in cancer patients with UGT1A1 polymorphisms.

Innocenti F, Ratain MJ. Innocenti F, et al. Among authors: ratain mj. Oncology (Williston Park). 2003 May;17(5 Suppl 5):52-5. Oncology (Williston Park). 2003. PMID: 12800608 Review.

8

UGT pharmacogenomics: implications for cancer risk and cancer therapeutics.

Desai AA, Innocenti F, Ratain MJ. Desai AA, et al. Among authors: ratain mj. Pharmacogenetics. 2003 Aug;13(8):517-23. doi: 10.1097/01.fpc.0000054116.14659.e5. Pharmacogenetics. 2003. PMID: 12893990

9

Pharmacogenomics: road to anticancer therapeutics nirvana?

Desai AA, Innocenti F, Ratain MJ. Desai AA, et al. Among authors: ratain mj. Oncogene. 2003 Sep 29;22(42):6621-8. doi: 10.1038/sj.onc.1206958. Oncogene. 2003. PMID: 14528287

10

"Irinogenetics" and UGT1A: from genotypes to haplotypes.

Innocenti F, Ratain MJ. Innocenti F, et al. Among authors: ratain mj. Clin Pharmacol Ther. 2004 Jun;75(6):495-500. doi: 10.1016/j.clpt.2004.01.011. Clin Pharmacol Ther. 2004. PMID: 15179404 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

571 results

Search Page